Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

PDL BioPharma Inc. (PDLI)

3.12   -0.01 (-0.32%) 07-15 16:00
Open: 3.13 Pre. Close: 3.13
High: 3.145 Low: 3.085
Volume: 406,947 Market Cap: 376M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.147 - 3.166 3.166 - 3.18
Low: 3.045 - 3.07 3.07 - 3.089
Close: 3.087 - 3.124 3.124 - 3.152

Technical analysis

as of: 2019-07-15 4:44:25 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 3.89     One year: 4.54
Support: Support1: 3.06    Support2: 2.90
Resistance: Resistance1: 3.33    Resistance2: 3.89
Pivot: 3.11
Moving Average: MA(5): 3.16     MA(20): 3.08
MA(100): 3.34     MA(250): 2.98
MACD: MACD(12,26): 0.03     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 54.76     %D(3): 67.69
RSI: RSI(14): 51.89
52-week: High: 3.89  Low: 2.25  Change(%): 21.9
Average Vol(K): 3-Month: 115680  10-Days: 83464

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PDLI has closed below upper band by 46.1%. Bollinger Bands are 28.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 08 Jun 2019 15:32:29 Z
PDL BioPharma (PDLI) Down 9.7% Since Last Earnings Report: Can It Rebound?

Thu, 30 May 2019 17:10:43 Z
PDL BioPharma's Royalties Help, Heavy Partner Reliance Hurts

Fri, 10 May 2019 17:01:51 Z
PDL BioPharma (PDLI) Q1 Earnings Top Mark, Revenues Rise Y/Y

Fri, 10 May 2019 00:58:22 Z
PDL Biopharma Inc (PDLI) Q1 2019 Earnings Call Transcript

Wed, 08 May 2019 15:56:43 Z
Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 120.66
Shares Float (M) 108.63
% Held by Insiders 2.47
% Held by Institutions 95.24
Shares Short (K) 17400
Shares Short P. Month (K)

Stock Financials

EPS -0.456
EPS Est. Current Year 0.610
EPS Est. Next Year 0.410
EPS Est. Next Quarter 0.130
Forward EPS 0.250
Book Value (p.s.) 5.620
PEG Ratio 1.53
Profit Margin -57.72
Operating Margin -11.70
Return on Assets (ttm) -0.8
Return on Equity (ttm) -8.3
Qtrly Rev. Growth -0.1
Gross Profit (p.s.) 0.514
Sales Per Share
EBITDA (p.s.) 0.017
Qtrly Earnings Growth 317.00
Operating Cash Flow (M) 4.61
Levered Free Cash Flow (M) 47.32

Stock Valuations

P/E -6.84
P/E Growth Ratio
P/BV 0.56
P/S 476530624.00
P/CF 81.66

Dividends & Splits

Dividend Yield
Dividend Pay Date 2016-06-13
Ex-Dividend Date 2016-06-02
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.